Close

Vaxess

MIMIX™ Infectious Disease: Making Vaccines Radically More Effective and Accessible

The U.S. National Institute of Allergy & Infectious Diseases (NIAID) has awarded Vaxess Technologies up to $2.85M to develop & commercialize its Mimix vaccine delivery system. Using intradermal microneedles for sustained delivery, the wearable unit is designed to mimic natural infection kinetics. The first human clinical trials of the platform […]

Read More